Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus

Volume: 44 Number: 4 November 1, 2016
  • Bahar T. Fındık
  • Rıdvan Say
  • Özlem Biçen Ünlüer
  • Rasime Demirel
  • Arzu Ersöz
EN TR

Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus

Abstract

In the present study, we have provided a strategy to block staphylococcal protein A SpA which acts as a viru- lence factor and increase lysozyme activity against the staphylococcal infection. For this purpose, polymeric antibodious nano IgG has synthesized according to photosensitive micro emulsion technique and developed some binding parts on nano IgG for lysozyme. The bioconjugation method based on aminoacid monomer-prote- in cross-linking applying photosensitation and conjugation approach ANADOLUCA on micro and nano-struc- tures by ruthenium-chelate based monomers has used. The antibacterial activities of polymeric nano-IgG and lysozyme cross-linked polymeric nano-IgG have investigated against to Staphylococcus aureus. The effects on S. aureus have determined using dilution plate method and turbidity method. In addition, the effects on S. au- reus of lysozyme cross-linked polymeric nano-IgG have determined using confocal laser scanning microscopy. The biocompatibility of nanobioconjugates has determined by flow cytometry. The results have shown that nanobioconjugates could be used as an effective mimic and antimicrobial agents.

Keywords

References

  1. 1. G.D. Wright, Bacterial resistance to antibiotics: enzymatic degradation and modification, Advanced Drug Delivery Reviews, 57 (2005) 1451-1470.
  2. 2. R. Satishkumar, A. Vertegel, Charge‐directed targeting of antimicrobial protein‐nanoparticle conjugates, Biotechnology and Bioengineering, 100 (2008) 403-412.
  3. 3. S.C. Yadav, A. Kumari, R. Yadav, Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation, Peptides, 32 (2011) 173-187.
  4. 4. E. Gustafssona, S. Karlssona, J. Oscarsson, P. Sogard, P. Nilsson, S. Arvidson, Mathematical modelling of the regulation of spa (protein A) transcription in Staphylococcus aureus, International Journal of Medical Microbiology 299, (2009) 65-74.
  5. 5. M. Askarian, A. Zeinalzadeh, A. Japoni, A. Alborzi, Z.A. Memish, Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran International Journal of Infectious Diseases, 13 (2009) 241-247.
  6. 6. R. Saginur, K.N, Suh, Staphylococcus aureus bacteraemia of unknown primary source: Where do we stand? International Journal of Antimicrobial Agents, 32 (2008) 2-25.
  7. 7. N. Palmqvist, G.J. Silverman, E. Josefsson, A. Tarkowski, Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus, Microbes and Infection, 7 (2005) 1501-1511.
  8. 8. L. Pan, F. Yue, J. Miao, L. Zhang, J. Li, Molecular cloning and characterization of a novel c-type lysozyme gene in swimming crab Portunus trituberculatus, Fish & Shellfish Immunology, 29 (2010) 286-292.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Bahar T. Fındık This is me

Rıdvan Say This is me

Özlem Biçen Ünlüer This is me

Rasime Demirel This is me

Arzu Ersöz This is me

Publication Date

November 1, 2016

Submission Date

-

Acceptance Date

-

Published in Issue

Year 2016 Volume: 44 Number: 4

APA
Fındık, B. T., Say, R., Ünlüer, Ö. B., Demirel, R., & Ersöz, A. (2016). Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus. Hacettepe Journal of Biology and Chemistry, 44(4), 477-486. https://izlik.org/JA34FF88SY
AMA
1.Fındık BT, Say R, Ünlüer ÖB, Demirel R, Ersöz A. Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus. HJBC. 2016;44(4):477-486. https://izlik.org/JA34FF88SY
Chicago
Fındık, Bahar T., Rıdvan Say, Özlem Biçen Ünlüer, Rasime Demirel, and Arzu Ersöz. 2016. “Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus”. Hacettepe Journal of Biology and Chemistry 44 (4): 477-86. https://izlik.org/JA34FF88SY.
EndNote
Fındık BT, Say R, Ünlüer ÖB, Demirel R, Ersöz A (November 1, 2016) Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus. Hacettepe Journal of Biology and Chemistry 44 4 477–486.
IEEE
[1]B. T. Fındık, R. Say, Ö. B. Ünlüer, R. Demirel, and A. Ersöz, “Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus”, HJBC, vol. 44, no. 4, pp. 477–486, Nov. 2016, [Online]. Available: https://izlik.org/JA34FF88SY
ISNAD
Fındık, Bahar T. - Say, Rıdvan - Ünlüer, Özlem Biçen - Demirel, Rasime - Ersöz, Arzu. “Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus”. Hacettepe Journal of Biology and Chemistry 44/4 (November 1, 2016): 477-486. https://izlik.org/JA34FF88SY.
JAMA
1.Fındık BT, Say R, Ünlüer ÖB, Demirel R, Ersöz A. Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus. HJBC. 2016;44:477–486.
MLA
Fındık, Bahar T., et al. “Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus”. Hacettepe Journal of Biology and Chemistry, vol. 44, no. 4, Nov. 2016, pp. 477-86, https://izlik.org/JA34FF88SY.
Vancouver
1.Bahar T. Fındık, Rıdvan Say, Özlem Biçen Ünlüer, Rasime Demirel, Arzu Ersöz. Lysozyme Cross-Linked Antibodious Destroyers Against Staphylococcus Aureus. HJBC [Internet]. 2016 Nov. 1;44(4):477-86. Available from: https://izlik.org/JA34FF88SY

HACETTEPE JOURNAL OF BIOLOGY AND CHEMİSTRY

Copyright © Hacettepe University Faculty of Science

http://www.hjbc.hacettepe.edu.tr/

https://dergipark.org.tr/tr/pub/hjbc